Transcript Highlights:

• all THC variants, including THCA.
• In the regulated cannabis industry, we work with total THC. Our labels will say total THC.
• THC.
• Our labels will say total THC THC.
• So it's about 54% THC.

Keywords: 1191, senate, all

Transcript Highlights:

• cognitive decline increase as the THC cognitive decline increase as the THC dose<00:31:12.960>
• Yes, the new THC potency limits cannabis concentrations maximum to 30% total THC.
• We do ban the infused THC.
• Yes, the new THC potency limits cannabis concentrations maximum to 30% total THC.
• We do ban the infused THC. max potency. We do ban the infused THC.

Keywords: 1187, senate, all

Transcript Highlights:

• It is defined as 0.3% delta-9 THC.
• Another loophole is that they only focus on delta-9 THC. There are other THC isomers in the plant.
• isomers, and that's where you see your delta-8 THC, delta-9 THC, or delta-10 THC, and create cannabinoids
• 25 nanogs of THC in their saliva. 25 nanogs of THC in their saliva.
• formats within safe THC limits. formats within safe THC limits.

Bills: HB1974, HB1853, HB1973, HB1574, HB2619, HB1966, HB1643, HB1671, HB2558, HB1854, HB2173, HB1575, HB2229, HB1535, HB1978, HB2508, HB1549, HB2187, HB1550, HB1977, HB2314, HB1871, HB2319, HB1591, HB1858, HB1898, HB2372, HB1765, HB2012, HB1706, HB1962, HB1963, HB1975, HB2009, HB2083, HB2224, HB1877, HB1959, HB1626, HB1665, HB2488, HB2456, HB2548, HB2207, HB1832, HB2079, HB1985, HB1618, HB2486, HB2242, HB2045, HB1703, HB2236, HB2480, HB1976, HB2287, HB2288, HB1777, HB276, HB1660, HB1676, HB1605, HB1751, HB1967, HB2383, HB2340, HB1946, HB2268, HB1950, HB2156, HB2118, HB1859, HB1863, HB1996, HB2114, HB2423, HB2429, HB2475, HB2534, HB2545, HB1813, HB1941, HB2474, HB2583, HB1576, HB1886, HB1939, HB2540, HB2590, HB2000, HB2163, HB2386, HB1691, HB1680, HB2516, HB1993, HB2442, HB1510, HB1958, HB1692

Keywords: HB1974, hearing loss, audiology, audiologist, hearing screening, hearing aids, cochlear implants, tele-audiology, communication access, assistive technology, speech-language pathology, deafness, hard of hearing, public health, kupuna, keiki, dementia, cognitive decline, fall prevention, State Health Planning and Development Agency

Transcript Highlights:

• level, what do you believe is a THC level that's too high, or what's a THC level that's sufficient?
• versus low-THC have said 10% THC is that cutoff.
• THC.
• So this one says 5 milligrams of THC and 10 milligrams of CBD.
• He began smoking THC regularly at age 15.

Keywords: 995, all

Summary: The Joint Committee on Cannabis Policy held its fourth hearing, with opening remarks from Senate Chair Adam Gómez and House Chair Dan Donahue emphasizing the committee’s broad agenda, including retail modernization, labor protections, advertising rules, sustainability, and financial resources. Testimony began with public health advocates supporting H.157/S.9 to ban cannabis billboard advertising, arguing that billboards normalize use for youth and are linked to cannabis-related harms such as psychosis, addiction, and cannabinoid hyperemesis syndrome. Witnesses cited research, family stories, and court decisions in Mississippi and Virginia upholding similar restrictions, while committee members questioned the scope of the state’s authority to regulate billboards on private property and the relevance of federal highway funding and federal cannabis law. The committee also heard testimony on H.175, a proposal to allow cannabis drive-through sales. A dispensary operator argued drive-throughs would improve access, especially for disabled customers and veterans, and said security and ID checks could be handled with cameras and staff screening. Committee members pressed him on how employees would assess impairment, whether drive-throughs could increase access for minors, and whether the industry should be treated like alcohol, with the witness responding that staff already refuse service to intoxicated customers and that education, not prohibition, is the better approach. Another bill, H.3982, would apply the bottle deposit law to carbonated hemp- or THC-infused beverages; the sponsor said the measure would standardize recycling requirements for products already sold in dispensaries and other markets, and members asked about container types and recycling compatibility. A major portion of the hearing focused on labor peace agreements, with UFCW representatives, cannabis workers, and Sen. Lydia Edwards supporting S.77/H.161. They said the bill would require cannabis businesses to remain neutral when workers seek to organize, arguing that unions improve safety, wages, benefits, and job stability in an industry they described as underregulated and prone to retaliation. Witnesses cited workplace hazards, wage theft, and the death of a worker at a Holyoke facility as examples of why stronger worker protections are needed. Committee members asked how the proposal differs from existing labor law, whether tying LPAs to licensing and renewal could create legal or administrative problems, and how other states handle similar requirements. No votes or final actions were taken during the hearing.

Transcript Highlights:

• THC is intoxicating. CBD is not.
• We have a 50% total THC.
• mentioned the combination flour and THC mentioned the combination flour and THC concentrate.<01:
• impacts and effects of high potency THC impacts and effects of high potency THC products.<01:02:
• certainly a limitation on the total THC certainly a limitation on the total THC by<01:05:28.559>

Keywords: 1187, senate, all

Transcript Highlights:

• RAND estimated the amount of THC that was produced by Washington cannabis producers, sold at licensed
• THC is the primary psychoactive component in cannabis, and by using this as a common unit of analysis
• Again, RAND estimated for us the pounds of THC that were produced, sold, and consumed.
• THC.
• from 146,000 pounds to 249,000 pounds of THC.

Summary: At the May 14, 2025 JLARC meeting, members approved the January 9 minutes and adopted the 2025–27 biennial work plan with a minor typo correction. Staff reviewed the new work plan studies, including a drug take-back program fee/expenditure review due in December 2025 and a state energy performance standard compliance review due in June 2027, and noted JLARC’s recent session activity, including several bills passed related to JLARC work and recommendations. The committee then heard a preliminary cannabis market study showing Washington businesses likely produced two to three times more cannabis than retailers sold in 2023. Staff and RAND said LCB’s data systems are incomplete and unreliable, limiting regulation, tax verification, and diversion tracking; they recommended that LCB submit a plan by year-end for collecting accurate data by the end of 2026. Members and LCB discussed the long timeline for a new traceability system, the causes of missing sales and weight data, overproduction, diversion, and the social equity program’s effect on producer licenses. JLARC also presented a preliminary hospital oversight report concluding that the Department of Health is late on many hospital inspections, does not verify third-party inspection standards, does not review adverse health event correction plans, and could make hospital data more accessible. The committee discussed fee funding, language access, and inspection timing, and DOH said it would work on a strategic plan and continue coordinating with JLARC. Members also heard a preliminary report on the public records survivor exemption, which found agencies are using it but need more guidance; JLARC recommended keeping the exemption and having the Attorney General provide additional training. Finally, the committee approved the DDA processes and staffing final report for distribution, which recommended performance metrics, stronger data quality controls, and workforce planning; DDA concurred. JLARC also introduced proposed study questions for a future DCYF juvenile rehabilitation review focused on safety, security, programs, staffing, education, and contraband, and the meeting adjourned after members asked about scope and facility conditions.

Transcript Highlights:

• Including tetrahydrocannabinolic acid, THC-A, of not more than 3%.
• So essentially, Subtributable THC per container, et cetera.
• This map reflects state regulatory policies for hemp-derived THC beverages as of October 2025.
• Hemp is just what they call the plants that have less than that 0.3 THC Delta-9.
• Hemp is just what they call the plants that have less than that point three THC Delta 9.

Keywords: Cannabis Retail Market, Joint Commission to Oversee the Transition of the Commonwealth into a, 976, house, all

Summary: The Joint Commission on Cannabis and Hemp Policy met for its first meeting of 2026, elected Senator Lashrecse Aird as chair and Delegate Paul Krizek as vice chair, confirmed a quorum, adopted the virtual participation policy, and heard member introductions. Opening remarks emphasized the commission’s ongoing charge under HJR 497 to oversee Virginia’s transition toward a regulated retail cannabis market, with leaders noting that cannabis possession and home cultivation are already legal but retail sales remain unregulated and that the commission’s work continues despite the veto of the 2026 retail market bill. The commission then received a virtual briefing from NCSL on federal cannabis and hemp developments. Presenters explained the federal rescheduling of certain cannabis products to Schedule III, stressing that it applies only to FDA-approved cannabis drugs and state medical cannabis products, does not legalize adult-use sales, and leaves unresolved issues such as banking and broader tax compliance. They also reviewed the 2026 federal hemp changes narrowing the hemp definition, effective November 12, 2026, and warned of enforcement, interstate commerce, and market-disruption concerns for hemp-derived products. Members asked questions about whether rescheduling could lead to decriminalization and about tax and compliance implications for states. Commission staff then reviewed Virginia’s cannabis-related legislation from the 2026 session. They summarized bills that became law, including a process for modifying certain pre-2021 marijuana-related sentences, a bill allowing the Department of Health to address cannabis oil use in hospitals and convene a work group on medical-care-facility access, and a medical cannabis labeling/delivery measure. They also described SB 543, which strengthened hemp and illicit cannabis enforcement by requiring license decals, creating penalties for unlicensed sales and false decals, authorizing cease-and-desist actions and seizures, establishing a public tip line, directing law-enforcement training, and creating a consumer-protection civil action for certain high-THC products. No public comments were offered, and the meeting adjourned without further action.

Transcript Highlights:

• IN 2014 SENATE BILL 1030 ESTABLISHED THE COMPASSIONATE MEDICAL CANNABIS ACT WHICH WOULD LEGALIZE LOW THC
• THE FIRST IS LOW THC CANNABIS THAT IS DISPENSED.
• AND THEN THE TESTING LABORATORY INSPECTIONS FOCUS ON THE USE OF INAPPROPRIATE TESTING METHODS AND THC
• I WANT TO GO BACK TO THE SLIDE WHERE WE MEASURE FISCAL YEAR 24 25 ARE TALKING ABOUT THE LOW DOSE THC
• CANVAS IN MILLIGRAMS AND DID YOU CHANGE HOW YOU ARE MEASURING AND HOW YOU CLASSIFY THC AND CBD?

Transcript Highlights:

• CBD and other cannabinoids into THC.
• That's a conversation, you know, for the feds if it's under 0.3 THC Delta 9 THC, then the answer would
• gummies and no-THC drinks.
• THC.
• rules for low THC gummies and no THC rules for low THC gummies and no THC drinks<01:59:16.159>

Keywords: 910, house, all

Transcript Highlights:

• WE WANT TO ADDRESS THE THC BEVERAGES IN THE BILL.
• WE APPRECIATE WE'VE HAD SEVERAL OF THOSE CONVERSATIONS IN THE BILL DOES ADDRESS THE THC BEVERAGES SO
• INDUSTRY STANDARDS IS ANYWHERE FROM 5 TO 8 G SO INSTEAD OF LIMITING THE WEIGHT, LIMIT THE THC CONTENT
• BY PROPOSING THC MILLIGRAMS CAPS AND AN EXCISE TAX.
• AT PRESENT 21 AND OLDER RECREATIONAL DON'T USE STATES HAVE THC AND EXCISE TAXES.

Transcript Highlights:

• These substances, including delta 8 THC and other isomers, are chemically similar to delta 9 THC.
• It comments about Delta 8, Delta 9, or any other THC isomer variant. THCA is not an isomer of THC.
• <01:33:36.639> We one part THC and one part CBD. We one part THC and one part CBD.
• We always treat THCA as a form of THC. We always treat THCA as a form of THC.
• allowed to sell THC at greater than.3%. allowed to sell THC at greater than.3%.

Keywords: 1191, senate, all

Transcript Highlights:

• I'm against THC. I'm against THC. You can drink wine. You can drink beer.
• You could be terminated if you have THC. THC doesn't go away like these other products.
• This THC that we're talking about, Kentucky hemp, is a safe product. Low octane, low THC levels.
• In fact, the THC content is regulated.
• it's a safe product, but there are THC it's a safe product, but there are THC products<01:00:26.640

Keywords: 958, all

Transcript Highlights:

• So people will talk about THC. Well, THC can mean a lot of things. I know you know that.
• So people will talk about THC. Well, THC can need a lot of things. I know you know that.
• It's got the THC potency range, so I'll draw your attention to smoking.
• Low-THC cannabis is less than 0.8% THC, but greater than 10% CBD.
• But things that are advertised as having THC are not all from our market.

Summary: The Senate Health Policy Committee received updates from the Agency for Health Care Administration and the Department of Health on implementation of 2024 health care laws. AHCA reviewed progress on workforce and reimbursement measures in Senate Bill 7016 and related bills, including FRAME and TEACH funding, graduate medical education reporting, behavioral health teaching hospitals, acute hospital care at home, advanced birth centers, non-emergent care access plans, and rural emergency hospitals. Agency officials said several programs are already operational or have begun payments, while others are still in rulemaking, federal approval, or report-preparation stages. Senators asked about timing, funding reversion concerns, and whether appropriated dollars would be spent on schedule, especially for behavioral health teaching hospitals and the new birth center category. The Department of Health then reported on practitioner licensure and public health programs. MQA described implementation of the Interstate Medical Licensure Compact, the Mobile Act licensure pathway, massage therapy enforcement changes, background screening expansion, liposuction safety requirements, pharmacist HIV post-exposure prophylaxis authority, and chiropractic dry needling. Public health staff updated the committee on FRAME and dental loan repayment, the Sinati screening grant program, the cancer research and innovation changes, the health care innovation council and loan program, the pediatric rare disease grant program, telehealth maternity care expansion, newborn screening for congenital CMV, the sickle cell registry and grants, and the swimming lesson voucher program. Members focused questions on how practitioners were being recruited to underserved areas, the pace of licensure approvals, and whether new programs were on track to use appropriated funds. The committee also heard a lengthy update from the Office of Medical Marijuana Use. The director reported more than 900,000 qualified patients, real-time seed-to-sale tracking now integrated across most dispensaries and labs, and ongoing compliance work on product testing, advertising, diversion, and patient safety. Senators questioned the decline in qualified physicians, how THC potency is labeled and verified, and what the agency can do about diversion to non-patients. The director said the office relies on complaints, inspections, lab audits, and coordination with law enforcement, and that patients can be suspended if violations are confirmed.

Transcript Highlights:

• President, this is a conference report on the THC bill.
• We removed the DUI language from the THC bill.
• Are these THC drinks.
• And then finally, we took the basic Senate bill for THC DUI, which was in the THC bill, took that basic
• We took the basic Senate bill for THC DUI, which was in the THC bill, and took that basic bill.

Keywords: 977, all

Transcript Highlights:

• These rules may include testing for THC levels, authorizing methods for testing THC, requirements for
• These rules may include testing for THC levels, authorizing methods for testing THC, requirements for
• These rules may include testing for THC levels, authorizing methods for testing THC, requirements for
• These rules may include testing for THC levels, authorizing methods for testing THC, requirements for
• These rules may include testing for THC levels, authorizing methods for testing THC, requirements for

Keywords: 926, house, all

Summary: The House took up Senate Bill 323, suspending the rules to consider it immediately. The bill was described as a broad agricultural measure with committee amendments and fiscal implications, and it was reported favorably by the Agriculture, Food Resiliency, and Forestry Committee, Ways and Means, and Appropriations. Members outlined sections dealing with milk market corrections, farm-to-school language, repeal of the obsolete pest control compact, pesticide applicator licensing changes, seed law updates, the Vermont Agricultural Credit Program, hemp regulation, and CAFO-related provisions. The Agriculture committee reported the bill out 7-0-1, and the effective date was described as July 1, 2026, except for the hemp provisions, which would take effect upon passage. Much of the discussion focused on the hemp sections. Supporters said the bill updates Vermont law to reflect federal changes and shifts hemp oversight from the Agency of Agriculture to the Cannabis Control Board. The hemp provisions would create registration and licensing requirements for hemp producers, processors, and certain hemp products; set fees; authorize testing, inspections, stop-sale orders, and administrative penalties; and allow rulemaking on product standards, labeling, insurance, additives, and age restrictions. Speakers said the changes were intended to help Vermont’s hemp industry maintain access to banking, insurance, and interstate commerce while improving consumer safety and regulatory clarity. Other agricultural provisions were also explained in detail. The bill would clarify milk producer hearing rights, update farm-to-school grant/contract language, remove outdated pest-control compact language, and adjust pesticide applicator exam and fee rules, including removing the limit on retakes and eliminating certain government applicator fees. It would also modernize seed labeling and definitions, transfer the Vermont Agricultural Credit Program into a new statutory structure under VEDA, and make conforming cross-reference changes in tax and cannabis fund statutes. The final sections would add a CAFO permit working group and require consultant training for state agencies on CAFO inspections, with those provisions contingent on future funding. Ways and Means noted the bill’s fee changes could affect state revenues, including an estimated hemp-related impact of roughly $10,000 to $90,000, though the exact effect was uncertain.

Transcript Highlights:

• content and the THC.
• We we're getting high on less than one percent THC.
• And now we're seeing products all the way up to 95% THC.
• We need to care because marijuana THC is a fat-soluble drug.
• , the high-potency THC that is now bouncing around in their brains.

Keywords: 999, senate, all

Transcript Highlights:

• Delta-8 THC is naturally found in cannabis as well as hemp plants.
• Delta-8 THC has some euphoric effect; it's about 70 to 80% as euphoric as Delta-9 THC.
• As a licensed dispensary, we do feel that any euphoric THC derivative or analog should be regulated.
• <00:21:10.880> is those remain and that Delta 8 THC is those remain and that Delta 8 THC is
• It'll show up as a positive for THC.

Keywords: 910, house, all

Summary: The committee on Consumer Protection and Commerce met on February 5, 2025, and heard testimony on several bills. HB 918, relating to labeling, drew support from the Department of Health, INDA (the nonwoven fabrics industry), and Hawaii Realtors. INDA said the bill aligns with do-not-flush labeling laws in other states but raised a concern about the six-month compliance deadline tied to FIFRA approval. In response to committee questions, witnesses explained that the bill is aimed mainly at disinfecting wipes, that most products are already labeled nationally, and that the proposed timing issue could be addressed by using Oregon’s approach. No vote was taken on the measure during the portion shown. The committee also heard HB 1482, relating to controlled substances. HPD supported the bill, and Aloha Green Holdings and the Department of Health both said they supported the intent but recommended technical amendments. Their testimony focused on clarifying the treatment of Delta-8 THC, distinguishing synthetic or artificially derived cannabinoids from naturally occurring forms, and avoiding confusion in the hemp law. Members asked whether Delta-8 would show up on drug tests; witnesses said it would test positive for THC and would not be distinguished from Delta-9. The bill was then set aside as the committee moved on. HB 981, relating to attorney’s fees, drew opposition from a law firm representing homeowners and associations, which argued the bill would limit access to legal services, favor developers and contractors, and make settlement harder. The witness suggested instead using existing consumer-protection fee-shifting concepts, and committee members explored whether a capped fee award or a broader attorney-fee rule would be more appropriate. The committee then took up HB 807 and HB 336, both relating to condominiums. HB 807 received support from the Green Infrastructure Authority and the Hawaii Bankers Association, while one testifier urged deferral over unresolved questions about commercial PACE financing; the bank association asked for more time to work with HGIA, and the chair indicated decision-making could be deferred to allow that discussion. On HB 336, the Community Associations Institute opposed the bill as removing checks and balances, while the Hawaii Workers Center and others supported it as a step toward clearer enforcement of health and safety issues in condominiums and rental housing.

Transcript Highlights:

• Every single one came back with a THC level that was not labeled on the outside of the can.
• Every single one came back with a THC level that was not labeled on the outside of the can.
• He said cannabinoids include THC, which is the one that gets people high, and that THC is limited by
• that also works with these THC that also works with these THC beverages<00:31:42.480> uh<
• When we say 100 milligrams, we're talking about CBD or THC?

Keywords: 958, all

Summary: The committee met with a quorum and took up Senate Bill 202, adopting a committee substitute before hearing testimony. Senator Julie Rocky Adams explained that the substitute would require the Cabinet for Health and Family Services to promulgate regulations by January 1, 2026 for intoxicating hemp-derived beverages, direct the University of Kentucky to study manufacturing, testing, distribution, sales, and consumer effects of those beverages, and impose a moratorium on their sale until July 1, 2026. Supporters, including Rep. Matt Cook, said the measure was intended as a consumer-protection step rather than a ban, citing concerns about youth access, inconsistent labeling, and the need for a clearer regulatory framework. Members asked about the legal status of the products, whether the bill could unintentionally sweep in non-intoxicating hemp beverages, and whether there was evidence of harm. Senators were told the products are legal under the federal farm bill loophole, but that testing has shown THC levels on sampled cans did not match labels and that current regulations do not specifically address intoxicating hemp-derived beverages. Senator Higdon said CHFS had already been authorized to regulate hemp products and was moving forward with regulations and enforcement, while Senator Meredith questioned whether a moratorium would unfairly punish businesses that had already invested in the market and suggested setting a THC standard instead. Public testimony then shifted to industry opposition. Jim Higdon of Cornbread Hemp said his company had invested heavily in a beverage line and argued the moratorium would function like a ban and harm small businesses. Dee Taylor of 502 Hemp and the Kentucky Hemp Association also opposed the moratorium, saying existing rules already require age limits, behind-the-counter sales, and licensed retailers, and arguing that a cap on milligrams would be preferable to a shutdown. He said retailers were seeing approved and unapproved products in the market and urged work with the Cabinet and ABC rather than a moratorium.

Transcript Highlights:

• of THC and CBD or a 20 to1 20% you know of THC and CBD or a 20 to1 20% you know 20<00:21:47.960> uh
• :22:41.760> important<00:22:42.240> therapeutic THC and THC is an important therapeutic
• THC and THC is an important therapeutic component<00:22:44.159> uh<00:22:44.520> as<00
• is the actual bud that's where the THC is the actual bud that's where the THC crystals<01:06:31.839
• <03:55:28.479> it cannabis if if if cannabis has THC it cannabis if if if cannabis has THC

Keywords: 1189, house, all

Transcript Highlights:

• Just limits the amount of THC in each edible and each package in order to protect kids.
• The mother observed The child eating a THC gummy.
• A two-year-old became Unresponsive after ingesting 9100 mg THC gummies.
• A four-year-old ingested THC gummies and had seizures.
• A nine-year-old was unresponsive in the home and transported after eating a THC lollipop.

Bills: SB1421, SB1427, SB1484, SB1503, SB1553, SB1557, SB1564, SB1566, SB1567, SB1591, SB1642, SB1794, SB1837, SB2044

Keywords: mental health, nonphysical intervention, training, youth care, conflict resolution, staff training, pediatric screenings, type 1 diabetes, health care providers, parental consent, reimbursement, state funding, public health, medicolegal investigation, medical examiner, coroner, sudden infant death syndrome, SIDS, sudden unexpected infant death, SUID